跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Rifemetrin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Rifemetrin
Approved
STANDARD
Rifemetrin
Kilitch Drugs (India) Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
345cd227e4d8f9ab
Company
Kilitch Drugs (India) Ltd.
Type
Standard
Approval Details
Approval Id
345cd227e4d8f9ab
Drug Approval Philippines Name
Rifemetrin
Product Name
Rifemetrin
Registration Number
DRP-10688-01
Brand Name
Rifemetrin
Generic Name
Methylergometrine maleate
Dosage Form
Solution for Injection (I.M./I.V.)
Dosage Strength
200 mcg/mL
Manufacturer
Kilitch Drugs (India) Ltd.
Importer
Nelpa Lifesciences, Inc
Distributor
Rifemedica Corporation
Issuance Date
27 October 2024
Expiry Date
08 November 2026
Pharmacologic Category
Oxytocic (Ergot Alkaloid)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
345cd227e4d8f9ab
Type
Standard
Back to Philippines FDA Approvals